Similar articles for PMID: 18089845

Year	Number of Results
1987	1
1989	1
1993	1
1994	1
1995	2
1996	4
1997	6
1998	4
1999	4
2000	6
2001	2
2002	8
2003	7
2004	3
2005	5
2006	6
2007	5
2008	14
2009	13
2010	9
2011	7
2012	7
2013	4
2014	4
2015	6
2016	2
2017	4
2018	2
2019	1
2020	2
2021	4
2022	2
2023	1
2024	0

1

2-Methoxymethyl-salvinorin B is a potent kappa opioid receptor agonist with longer lasting action in vivo than salvinorin A.

Wang Y, Chen Y, Xu W, Lee DY, Ma Z, Rawls SM, Cowan A, Liu-Chen LY. Wang Y, et al. J Pharmacol Exp Ther. 2008 Mar;324(3):1073-83. doi: 10.1124/jpet.107.132142. Epub 2007 Dec 18. J Pharmacol Exp Ther. 2008. PMID: 18089845 Free PMC article.

2

Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo.

Wang Y, Tang K, Inan S, Siebert D, Holzgrabe U, Lee DY, Huang P, Li JG, Cowan A, Liu-Chen LY. Wang Y, et al. J Pharmacol Exp Ther. 2005 Jan;312(1):220-30. doi: 10.1124/jpet.104.073668. Epub 2004 Sep 21. J Pharmacol Exp Ther. 2005. PMID: 15383632

3

Comparison of the diuretic effects of chemically diverse kappa opioid agonists in rats: nalfurafine, U50,488H, and salvinorin A.

Inan S, Lee DY, Liu-Chen LY, Cowan A. Inan S, et al. Naunyn Schmiedebergs Arch Pharmacol. 2009 Mar;379(3):263-70. doi: 10.1007/s00210-008-0358-8. Epub 2008 Oct 17. Naunyn Schmiedebergs Arch Pharmacol. 2009. PMID: 18925386

4

Sex difference in κ-opioid receptor (KOPR)-mediated behaviors, brain region KOPR level and KOPR-mediated guanosine 5'-O-(3-[35S]thiotriphosphate) binding in the guinea pig.

Wang YJ, Rasakham K, Huang P, Chudnovskaya D, Cowan A, Liu-Chen LY. Wang YJ, et al. J Pharmacol Exp Ther. 2011 Nov;339(2):438-50. doi: 10.1124/jpet.111.183905. Epub 2011 Aug 12. J Pharmacol Exp Ther. 2011. PMID: 21841040 Free PMC article.

5

Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation.

Li JG, Zhang F, Jin XL, Liu-Chen LY. Li JG, et al. J Pharmacol Exp Ther. 2003 May;305(2):531-40. doi: 10.1124/jpet.102.045559. Epub 2003 Jan 24. J Pharmacol Exp Ther. 2003. PMID: 12606694

6

Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents.

Kivell BM, Paton KF, Kumar N, Morani AS, Culverhouse A, Shepherd A, Welsh SA, Biggerstaff A, Crowley RS, Prisinzano TE. Kivell BM, et al. Molecules. 2018 Oct 11;23(10):2602. doi: 10.3390/molecules23102602. Molecules. 2018. PMID: 30314288 Free PMC article.

7

Agonist-Dependent and -Independent κ Opioid Receptor Phosphorylation: Distinct Phosphorylation Patterns and Different Cellular Outcomes.

Chiu YT, Chen C, Yu D, Schulz S, Liu-Chen LY. Chiu YT, et al. Mol Pharmacol. 2017 Nov;92(5):588-600. doi: 10.1124/mol.117.108555. Epub 2017 Sep 11. Mol Pharmacol. 2017. PMID: 28893975 Free PMC article.

8

Determination of sites of U50,488H-promoted phosphorylation of the mouse κ opioid receptor (KOPR): disconnect between KOPR phosphorylation and internalization.

Chen C, Chiu YT, Wu W, Huang P, Mann A, Schulz S, Liu-Chen LY. Chen C, et al. Biochem J. 2016 Feb 15;473(4):497-508. doi: 10.1042/BJ20141471. Epub 2015 Dec 3. Biochem J. 2016. PMID: 26635353 Free PMC article.

9

Pharmacological characterization of ATPM [(-)-3-aminothiazolo[5,4-b]-N-cyclopropylmethylmorphinan hydrochloride], a novel mixed kappa-agonist and mu-agonist/-antagonist that attenuates morphine antinociceptive tolerance and heroin self-administration behavior.

Wang YJ, Tao YM, Li FY, Wang YH, Xu XJ, Chen J, Cao YL, Chi ZQ, Neumeyer JL, Zhang A, Liu JG. Wang YJ, et al. J Pharmacol Exp Ther. 2009 Apr;329(1):306-13. doi: 10.1124/jpet.108.142802. Epub 2009 Jan 9. J Pharmacol Exp Ther. 2009. PMID: 19136637 Free PMC article.

10

Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations.

Chavkin C, Sud S, Jin W, Stewart J, Zjawiony JK, Siebert DJ, Toth BA, Hufeisen SJ, Roth BL. Chavkin C, et al. J Pharmacol Exp Ther. 2004 Mar;308(3):1197-203. doi: 10.1124/jpet.103.059394. Epub 2004 Jan 8. J Pharmacol Exp Ther. 2004. PMID: 14718611

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

131 results

Results by year